Stay updated on Tagraxofusp in CD123+ AML Clinical Trial
Sign up to get notified when there's something new on the Tagraxofusp in CD123+ AML Clinical Trial page.

Latest updates to the Tagraxofusp in CD123+ AML Clinical Trial page
- Check5 days agoChange DetectedThe change set adds a new revision entry, v3.5.4, and removes the prior revision, v3.5.3, from the study record history. This reflects an update to the page's revision history rather than a change to the study data.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedA site release/version update is reflected on the page (moving from one revision identifier to the next) without indicating any change to the trial record itself.SummaryDifference0.1%

- Check34 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision v3.5.0 was added and the previous v3.4.3 was removed from the Record History. This updates the version history displayed for the study record.SummaryDifference0.1%

- Check70 days agoChange DetectedRecord history now includes Revision: v3.4.3 and no longer lists Revision: v3.4.2.SummaryDifference0.1%

- Check98 days agoChange DetectedAdded a new revision entry (v3.4.2) to the record history and removed the funding-status notice along with the earlier Revision: v3.4.1 entry.SummaryDifference0.9%

Stay in the know with updates to Tagraxofusp in CD123+ AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tagraxofusp in CD123+ AML Clinical Trial page.